Firas Fahum
- 4.5 良い • 156 レビュー
- 31年の経験
- イスラエル, テルアビブ, Sourasky Medical Center (Ichilov)
Dr. Achinoam Socher is a Neurologist and Movement Disorder Specialist at Tel Aviv Sourasky Medical Center in Tel Aviv, Israel. He is known for his skill in diagnosing and treating complex neurological conditions. His main focus is on movement disorders.
Dr. Socher is a key member of the Neurology Department. He takes part in both clinical care and research. He works at one of Israel’s top hospitals, which is known for its large number of patients and advanced neurological services.
He has helped develop new treatment protocols and has taken part in clinical studies. These efforts have improved patient care. Dr. Socher holds professional accreditations that reflect his dedication to high medical standards.
2015 - 2015
Medipol Üniversitesi Parkinson Hastalığı ve Hareket Bozuklukları Merkezi
2009 - 2009
Medicalpark Bahçelievler Hastanesi
1999 - 2004
Medicalpark Bahçelievler Hastanesi
1997 - 2009
Amerikan Hastanesi
1997 - 1997
VKV Amerikan Hastanesi
1995 - 1995
Division of Neurosurgery, Toronto Western Hospital Research Fellow
1995 - 1995
Department of Neurosurgery, The Johns Hopkins Hospital
1995 - 1997
Toronto Western Hospital,
1994 - 1994
Division of Neurosurgery, Toronto Western Hospital
1992 - 1992
Department of Neurosurgery, University of Virginia
1992 - 1992
Department of Neurosurgery, University of Washington
1992 - 1992
İsrail Kudüs, The European Association of Neurosurgical Societies European
1991 - 1991
İspanya Zaragoz- The European Association of Neurosurgical Societies European
1990 - 1990
Glasgow, Scotland, İngiltere
1990 - 1990
Glasgow ve Edinburg, The British Council
1990 - 1990
Glasgow ve Edinburg, The British Council1994
Marmara University Institute of Health Sciences, Neurophysiology
1993
Marmara University Faculty of Medicine, Neurosurgery and Neurosurgery
1989
Marmara University Faculty of Medicine, Neurosurgery and Neurosurgery
1983
Hacettepe University, Faculty of Medicine
1983
Hacettepe University, Faculty of Medicine
マルセル・ディネの職歴
現在まで10年5ヶ月、2013年6月より
院長
Kplus、St. Lukas クリニック
脳卒中部門およびてんかん学を含む神経内科クリニックの責任者
2年1ヶ月、2011年5月 - 2013年5月
上級医師、研究グループリーダー
テュービンゲン大学病院、ゲルティ臨床脳研究所
6年11ヶ月、2004年6月 - 2011年4月
研修医、上級医師、研究グループリーダー
デュッセルドルフ大学病院、神経内科
完全なプロフィールを閲覧するにはサイトにログインしてください。
マルセル・ディネの学歴
2年1ヶ月、2011年5月 - 2013年5月
てんかん学
テュービンゲン神経内科大学病院、ゲルティ臨床脳研究所
てんかん学、自己免疫性脳炎、てんかん重積状態、人工多能性幹細胞
6年11ヶ月、2004年6月 - 2011年4月
神経内科学
デュッセルドルフ・ハインリッヒ・ハイネ大学
臨床神経内科学、神経内科集中治療、神経回路網
2年8ヶ月、2001年11月 - 2004年6月
神経科学
ハンブルク分子神経生物学センター(ZMNH)
幹細胞、神経再生
3年5ヶ月、1998年6月 - 2001年10月
神経内科学
RWTH-Aachen
6年8ヶ月、1991年10月 - 1998年5月
医学
RWTH-Aachen
Dr. Alexandru Cristescu is a neurosurgeon with strong expertise in brain and spine surgery. He completed his neurosurgery residency at leading hospitals in France. There, he received advanced training in his field. Dr. Cristescu specializes in brain tumor removal, spinal surgery, and minimally invasive neurosurgical procedures.
He is known for his precision and commitment to patient-centered care. Dr. Cristescu aims for the best possible surgical outcomes. He uses advanced surgical techniques and focuses on complex neurosurgical cases.
• Leading neurologist
• Doctor of Medical Sciences
• Postdoctoral Fellow at the University of Texas, Harvard University and Dartmouth College
• Has extensive clinical experience in preoperative assessment of resistant epilepsy, localization of epileptic foci and neurophysiological monitoring of various surgical operations
• Introduced the use of propofol for the Wada test in China, applied cortical electrical stimulation and high-frequency oscillations to localize epileptic foci, greatly improving the safety and efficiency of operations
• Author of more than 50 scientific articles, of which about 30 in international journals
• The Journal of Neuroscience in December 2003 featured the doctor on the cover as the author of a scientific article on the discovery of the mechanisms of memory impairment in epilepsy at the cellular level
• Lectured at the Department of Neurology, State University of New York College of Medicine, Brooklyn and the Department of Neurology, University of California, Los Angeles
• Multiple recipient of a special grant for epilepsy research in the United States, a laureate of funding from the National Natural Science Foundation, the Ministry of Science and Technology, the Ministry of Education, and the research and development funds of Peking University Hospital
• Lead author and co-author of several monographs: “Epilepsy Surgery” (2006), “Clinical Guidelines for Epilepsy” (2006), “Aphasia” (2006), “Clinical Diagnostic Guidelines: Section on Epilepsy” (2007), “Modern Clinical Electroencephalography” (2009), “Treatment of Epilepsy” (2010), “Guidelines for the Treatment of Diseases of the Nervous System” (2010), “Intraoperative Neurophysiological Monitoring” (2014)
• Member of the Epilepsy and Electroencephalography Group of the Chinese Neurological Society
• Chairman of the Neurophysiological Monitoring Group of the Chinese Neurosurgical Society
• Vice Chairman of the Expert Committee on Neurophysiological Monitoring during Surgeries, Chinese Medical Association
• Vice Chairman of the Neurophysiology Group of the Peripheral Neurological Committee
• Vice Chairman of the Clinical Neurophysiological Committee of the China Association of Research Hospitals
• Chairman of the Management Committee of the Epilepsy Care Foundation of China Primary Health Care Foundation
• Chairman of the Scientific Committee of the Epilepsy Care Foundation of the Chinese Medical Association
• Deputy Secretary General of the Chinese Epilepsy Association
• Permanent member of the Electroencephalography and Clinical Neurophysiology Division of the Chinese Epilepsy Association
• Vice Chairman of the Committee on Syncope and Sudden Death, Chinese Society of Hypertension
• Vice Chairman of the Neurosurgical Committee of the Beijing Medical Association
• Member of the International Society for Intraoperative Neurophysiological Monitoring
• Representative of the Asian region of the International Society for Intraoperative Neurophysiological Monitoring
Specializes in diagnostics and treatment of:
• epilepsy in children
• epilepsy in adults
• movement disorders
• sleep disorders
• neuralgia
License (MD)
Field: Medicine
University: Istanbul University
Year: 1987
Residency
Field: Cardiovascular Surgery
Institution: Siyami Ersek Heart Center
Years: 1988–1994
Clinical Fellowship
Field: Cardiovascular Surgery
Institution: University of Ottawa Heart Center (Canada)
Years: 1994–1995
Assistant Professor
Field: Cardiovascular Surgery
Institution: Siyami Ersek Heart Center
Years: 1995–2008
Professor
Field: Cardiovascular Surgery
Institution: Altınbaş University
Years: 2014–2019
Membership in Scientific and Professional Organizations
-Turkish Society of Cardiovascular Surgery
-European Society for Cardiovascular Surgery
-European Society for Vascular Surgery
Since 1998 he has been Director of the Epilepsy Unit at the Ruber International Hospital in Madrid, a pioneering centre for the diagnosis, medical and surgical treatment of epilepsy in children and adults.
More than 150 neurologists and neurophysiologists from Spain and Latin America have been trained here, and several of its students have successfully opened epilepsy centres in other public and private hospitals, both in Spain and abroad.
The program he directs has become a pioneer in Spain in the field of genetic diagnosis of complex epilepsies and advanced treatments such as drug repositioning, interstitial laser treatment, deep electrodes and gamma radiosurgery, which are used in patients with refractory epilepsy.
Dr. Antonio Gil-Nagel is a professor at the IE University, is an Ad Honorem Professor at the Center for Biomedical Technology of the Polytechnic University of Madrid (CTB) and is Director of the Epilepsy Department at the Francisco Vitoria University of Madrid.
He was a founding member of the European Epilepsy Research Network and the European Association for Epilepsy Monitoring. He is also active in international research projects such as EpiCare and the European Epilepsy Brain Bank and has held relevant positions in international institutions such as the International Bureau for Epilepsy (IBE), the International League Against Epilepsy (ILAE), the European Federation of Neurological Societies (EFNS) and the World Federation of Neurology (WFN).
Dr. Gil-Nagel has directed numerous clinical trials and research studies in the field of epilepsy, especially in orphan epilepsies such as Dravet syndrome, Lennox-Gastaut syndrome and other epileptic and developmental encephalopathies. The Epilepsy Program he directs is an international benchmark in the development of pharmacological research. He has been the Principal Investigator of phase II and III clinical trials, including numerous clinical trials and non-pharmacological treatments (epilepsy surgery, electrical stimulation, ketogenic diet and gamma knife). His research is funded by European Union funds and the Public Innovation Agency of the Ministry of Science and Innovation of the Spanish Government. Their dedication to research and the development of new treatments allows them to accelerate the treatment of their patients with new treatments.
In addition to being a frequent speaker at national and international conferences, he has authored several books on epilepsy and electroencephalography and has numerous publications on epilepsy in journals such as Annals of Neurology, Brain, Epilepsy, European Journal of Neurology, Journal of Neurology, Nature Neurology, Neurology, and the New England Journal of Medicine, among others. He has authored 165 Scopus-indexed articles with 5,265 citations and an h-index of 35.
In 2021, his team received the Innovative Small and Medium Enterprise Award for the project on mesial temporal lobe epilepsy and encephalocele (Ministry of Science and Innovation, Spain), and in 2012, the Scientific Award from the Epilepsy Group of the Spanish Society of Neurology (SEN).
Dr. Hill-Nagel is a leading international figure in the field of epileptology, a recognized expert in the diagnosis and treatment of genetic epilepsy and the surgical approach to its correction. His distinguished professional career includes many years of experience in leading medical institutions in the United States and Europe, as well as active participation in international research and educational programs.
Dr. Hill-Nagel not only advances the science of neurology on a global level, but also successfully implements cutting-edge treatment methods, improving the lives of thousands of patients around the world.
2005 – 2011 | Kocaeli University, Faculty of Medicine, Kocaeli, Turkey
M.D. Degree
2013 – 2019 | Erenköy Mental Health and Neurology Training and Research Hospital, Istanbul, Turkey
Neurology Residency Program
English – Very Advanced
Artvin Borçka State Hospital, Artvin, Turkey
General Practitioner (Compulsory Service)
2011 – 2012
Erenköy Mental Health and Neurology Training and Research Hospital, Neurology Department, Istanbul, Turkey
Resident Physician
2013 – 2019
Siirt State Hospital, Siirt, Turkey
Neurology Specialist (Compulsory Service)
2019 – March 2021
Private Pendik Medical Park Hospital, Istanbul, Turkey
Neurology Specialist
April 3, 2021 – April 10, 2024
Bahçeşehir University Faculty of Medicine, Department of Neurology, Istanbul, Turkey
Assistant Professor
April 19, 2021 – June 1, 2024
Medipol Acıbadem Regional Hospital, Istanbul, Turkey
Associate Professor of Neurology
April 22, 2024 – Present
Istanbul Medipol University Faculty of Medicine, Department of Neurology, Istanbul, Turkey
Associate Professor of Neurology
November 11, 2024 – Present
Turkish Neurology Society
Turkish Medical Association
International Parkinson and Movement Disorder Society
Turkish Neurology Society Neurorehabilitation Working Group
Global Migraine and Pain Society
International Headache Society
Turkish Parkinson’s Disease Society
Turkish Alzheimer Association, Kadıköy Branch
Parkinson’s disease and other movement disorders
Migraine and other headache disorders
Sleep disorders
Dementia and Alzheimer’s disease
EEG, Polysomnography (PSG), Multiple Sleep Latency Test (MSLT)
Botulinum toxin injections for movement disorders
Nerve blocks and botulinum toxin for headache management
Epilepsy
Dr. Ali Osman Mucuoglu is a neurosurgeon. He completed his neurosurgery residency at Dokuz Eylül University from 2013 to 2019 after graduating from Eskişehir Osmangazi University in 2012 (2005–2012). He worked at Dokuz Eylül University and Muş State Hospital from 2019 to 2021. He has practiced at Atlas University Hospital since 2021.
He has five publications. These include a case report in the International Journal of Surgery Case Reports that has been cited seven times. He also reported on 3D printer‑assisted transsphenoidal hypophysectomy and on emergency minimally invasive intracerebral hemorrhage (ICH) surgery. He delivered an oral presentation at the 33rd Turkish Neurosurgical Society Congress in 2019.
He is a member of the Turkish Neurosurgical Society, the European Association of Neurosurgical Societies, and the Istanbul Chamber of Medicine. His advanced training includes spinal surgery courses in 2016 and 2017, the European Training Course on Head Injury and Functional Neurosurgery in 2017, and Surgical Neuroanatomy in 2017. He also holds an animal experimentation certificate from 2016.
Dr. Mustafa Yavuz Samanci is an Associate Professor of Neurosurgery at Medipol Acıbadem District Hospital in Istanbul. He has specialized training in stereotactic, functional, and pediatric neurosurgery. Dr. Samanci completed a clinical fellowship in Gamma Knife Radiosurgery. He has also finished advanced programs in spinal cord and peripheral nerve stimulation. He received several TÜBİTAK postdoctoral research fellowships and the Prof. Dr. Hakan Caner Overseas Education Scholarship from the Turkish Neurosurgical Society.
Dr. Samanci is an active member of several national and international neurosurgical societies. These include the Turkish Neurosurgical Society, the International Parkinson and Movement Disorder Society, and the European Society for Stereotactic and Functional Neurosurgery. He has served on editorial boards and scientific committees. His work reflects significant contributions to academic neurosurgery and research.
Dr. Halil Can is a Professor of Neurosurgery (2025; Associate Professor 2020). He completed neurosurgical training at Istanbul University–Istanbul Faculty of Medicine in 2007. His clinical focus includes endoscopic and microsurgical spine surgery for fractures, tumors, and degenerative disease; advanced pain procedures; endoscopic skull base and pituitary surgery; and neurovascular, neuro-oncologic, and peripheral nerve surgery.
He has 21 international peer-reviewed papers (SCI/SSCI). Topics include cadaveric morphometry of Kambin’s triangle and the transforaminal triangular working zone, lumbar arterial and anterior approach anatomy, and an in vitro test of a new lumbar fixation device.
His clinical studies include a single-team series of 81 posterior circulation aneurysms, with 13 flow-diversion cases. He also reported five spinal cavernous malformation cases. He conducted Phase I safety and feasibility stem-cell trials in pediatric hypoxic-ischemic encephalopathy and in chronic complete spinal cord injury.
Dr Romero Imbroda is an academic of the Royal Academy of Medicine of Eastern Andalusia and a Fellow of the European Board of Neurology, as well as a Member of the Board of Directors of the
Andalusian Society of Neurology. He combines his medical practice with his teaching role at the University of Granada, where he is a Lecturer and has been a Member of the Internal Residential Doctor Assessment Committee in Melilla until 2017.
He is the author of several national and international scientific publications. He has also participated in research projects associated with treatments for multiple sclerosis.
Professional Experience:
• 2020: President of the Andalusian Society of Neurology
• 2019: Head of the Units at the Quirónsalud Malaga and Marbella Hospitals
• 2017-2021: Neurologist at the Regional Malaga University Hospital.
• 2016-2017: Lecturer at the University of Granada.
• 2009-2017: Neurologist at the Imbrain Neuroscience Clinic. Melilla.
• 2009-2017: Neurologist at the Melilla Hospital.
• 2008-2009: Neurologist at the Virgen de las Nieves Hospital. Granada.
• 2004-2008: Neurologist at the Carlos Haya Hospital. Malaga.
Academic Training:
• 2017: Innovation and Leadership in Neurology. Business Institute. Madrid.
• 2014: Educational Commission for Foreign Medical Graduates. United States.
• 2011-2012: Management of Integrated Health Services. ESADE. Madrid.
• 2010: Neurologists for the Future. Spanish Neurology Society.
• 2010: Master in Tissue Engineering. University of Granada.
• 2010: Doctorate at the University of Granada. Summa Cum Laude. 2010.
• 2004-2008: Neurology specialist at the Carlos Haya Hospital. Malaga.
• 1997-2003: University Graduate in Medicine at the University of Granada.
The Neurology Unit of the Quirónsalud Marbella Hospital specialises in the study and treatment of conditions associated to the nervous system, the brain, the spinal cord, the peripheral nerves and the muscles. We have the most advanced technology that enables us to make accurate and personalised diagnoses and treatments in the study of patients with complex diagnoses and treatments (MRI, CT scan,electroencephalogram, transacranial doppler ultrasound, cerebral arteriogramand neuropschycological testing).
We offer our patients highly-specialised treatments for cerebrovascular and neuromuscular diseases, Parkinson's Disease, headaches and migraine, epilepsy, multiple sclerosis, peripheral neuropathies, infections of the nervous system, movement disorders, dementia and other cognitive conditions, paediatric neurology, sleep disorders, tumours and complications deriving from injuries to the spine and the head.
Professional experience
Since 2006, he has been Head of the Neurology Department at the Quironsalud University Hospital of Madrid and the Ruber Juan Bravo Hospital.
Professor of Medicine at the Faculty of Biomedical Sciences of the European University of Madrid, holds the national accreditation of Professor of Medical Sciences (issued by ANECA).
Doctor of Medicine, Complutense University of Madrid (UCM). Award for Outstanding Doctoral Thesis (UCM, 2004): Study on the relationship of human herpes virus 6 as an environmental factor in multiple sclerosis.
Membership in scientific societies
National and International Principal Investigator in Neuroscience at Quironsalud Madrid (June 2015 – present)
President of the Research Committee of the Quironsalud University Hospital of Madrid (2012 to present).
Member of the Research Committee of the San Carlos Clinical Hospital (2012-2015).
Member of the Council of the Faculty of Medicine of the Complutense University of Madrid (2011-2015).
Research and Teaching
Principal investigator of 100 national and international clinical trials.
7 FIS research projects from the Carlos III Institute of Health (the last 5 as principal investigator).
10 projects from private foundations, received on a competitive basis (7 as principal investigator).
He has authored 139 international articles with a total impact factor of 949,917 and 4,552 citations. 38 books and book chapters with an H-factor of 34 (2018).
His publications stand out in journals that have the greatest global impact on research, such as the New England Journal of Medicine and the Lancet.
Dr. Rafael Arroyo has given over 300 international and national presentations at various Congresses.
Education :
Professor of Medicine at the Faculty of Biomedical Sciences of the European University of Madrid and holds the national accreditation of Professor of Medical Sciences (issued by ANECA).
Dr. Mehmet Tonge is a neurosurgeon with expertise in Stereotactic and Functional Neurosurgery. He specializes in MR Guided Focused Ultrasound, deep brain stimulation, Gamma Knife Radiosurgery, and surgery for movement disorders, pain, and spasticity.
Dr. Tonge has published 32 articles in international and national journals and written 12 book chapters. He has presented 92 oral and poster presentations and delivered 41 invited lectures. He completed a Deep Brain Stimulation Fellowship at Maastricht University and finished the 4-year EANS training cycle. Dr. Tonge is known for his research and clinical work in functional neurosurgery.
Dr. Eduard Linecki is a neurologist at Hadassah Medical Center with more than 23 years of clinical experience. He focuses on neurology, polyneuropathy, and neurooncology. He has strong expertise in managing and treating Parkinson's disease.
Dr. Linecki earned his medical degree in 1996. He completed his internship at Hadassah in 2001. He is known for achieving good results in Parkinson's disease therapy. He is also skilled in treating complex nervous system disorders.
Professor Zvi Israel is a renowned neurosurgeon and one of the best doctors in Israel according to Forbes. He is an expert in functional neurosurgery and has extensive experience in the treatment of chronic depression, tinnitus, epilepsy, and motor dysfunction. He is the director of the Functional and Restorative Surgery Unit at Hadassah Medical Center and has authored over 70 articles in neurosurgery. Professor Israel is a member of the Israeli Neurosurgical Society and the Israeli Society for Palliative Medicine.
Dr. Ela Simay Zengin is a neurologist. She completed her medical training at Dokuz Eylül University, Başkent University, and Acıbadem University. She has worked at Bitlis Tatvan, Sirnak, and Cizre State Hospitals.
Dr. Zengin treats Alzheimer’s disease, epilepsy, migraines, multiple sclerosis, Parkinson’s disease, and stroke. She uses advanced treatments, including apomorphine pump therapy, botulinum toxin injections, and migraine vaccines.
She is a member of the Turkish Neurology Association, American Academy of Neurology, European Academy of Neurology, and International Parkinson and Movement Disorder Society.
Dr. Ulvi Samadzade is a neurologist with training from Azerbaijan State Medical University, Gazi University, and Dokuz Eylul University Hospital. He diagnoses and treats neurological disorders such as Alzheimer’s disease, epilepsy, movement disorders, stroke, migraine, and multiple sclerosis.
Dr. Samadzade uses advanced treatments, including botulinum toxin injections, intravenous immunoglobulin (IVIG) therapy, migraine vaccines, and plasmapheresis. He practices at İzmir University of Economics Medical Point Hospital.
He is a member of several professional organizations. These include the Multiple Sclerosis Research Association, Turkish Neurological Society, European Academy of Neurology, and the International Parkinson and Movement Disorder Society (MDS).